VolitionRx Balance Sheet Health
Financial Health criteria checks 2/6
VolitionRx has a total shareholder equity of $-8.7M and total debt of $4.8M, which brings its debt-to-equity ratio to -55.5%. Its total assets and total liabilities are $28.0M and $36.7M respectively.
Key information
-55.5%
Debt to equity ratio
US$4.83m
Debt
Interest coverage ratio | n/a |
Cash | US$20.73m |
Equity | -US$8.71m |
Total liabilities | US$36.66m |
Total assets | US$27.95m |
Recent financial health updates
No updates
Recent updates
Do Institutions Own VolitionRx Limited (NYSEMKT:VNRX) Shares?
Mar 17This Insider Has Just Sold Shares In VolitionRx Limited (NYSEMKT:VNRX)
Feb 10Market Sentiment Around Loss-Making VolitionRx Limited (NYSEMKT:VNRX)
Jan 27Have Insiders Been Selling VolitionRx Limited (NYSEMKT:VNRX) Shares This Year?
Dec 29What Type Of Shareholders Own The Most Number of VolitionRx Limited (NYSEMKT:VNRX) Shares?
Nov 30Financial Position Analysis
Short Term Liabilities: VNRX has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: VNRX has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: VNRX has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: VNRX's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: VNRX has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: VNRX is forecast to have sufficient cash runway for 8 months based on free cash flow estimates, but has since raised additional capital.